The aim of the invention is the treatment of neurodegenerative diseases or other applicable pathologies by means of the intranasal application of a composition obtained from at least one blood compound and having growth factors or by means of a therapeutic substance obtained from said composition and the composition itself. It is guaranteed that the composition reaches the central nervous system in an effective way from the point of view of treatment and at the same time in a safe form for the patient.
